Clinical implications of HER2 mRNA expression and intrinsic subtype in refractory HER2-positive metastatic breast cancer treated with pan-HER inhibitor, poziotinib

Kim, JY; Park, K; Im, SA; Jung, KH; Sohn, J; Lee, KS; Kim, JH; Yang, Y; Park, YH

Park, YH (corresponding author), Sungkyunkwan Univ, Samsung Med Ctr, Dept Med, Div Hematol Oncol,Sch Med, 81 Irwon Ro, Seoul 06351, South Korea.

BREAST CANCER RESEARCH AND TREATMENT, 2020; 184 (3): 743

Abstract

Introduction We explored clinical implication of intrinsic molecular subtype in human epidermal growth factor receptor 2 (HER2) + metastatic breast ca......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索